Gateway Advisory LLC acquired a new stake in Insulet Co. (NASDAQ:PODD – Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 549,887 shares of the medical instruments supplier’s stock, valued at approximately $550,000. Other large investors also recently bought […]
Equities researchers at StockNews.com began coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a note issued to investors on Thursday. The firm set a “hold” rating on the medical instruments supplier’s stock. A number of other brokerages have also commented on PODD. Wells Fargo & Company cut their price target on Insulet […]
StockNews.com started coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the medical instruments supplier’s stock. PODD has been the topic of several other reports. JPMorgan Chase & Co. cut their price objective on shares of Insulet from $365.00 to $325.00 […]
Clearstead Advisors LLC boosted its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 559.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 145 shares of the medical instruments supplier’s stock after purchasing an additional 123 shares during the quarter. Clearstead […]
Y Intercept Hong Kong Ltd cut its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 14.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,038 shares of the medical instruments supplier’s stock after selling 343 shares during the quarter. Y Intercept […]